Emerging Approaches for Solid Tumor Treatment Using CAR-T Cell Therapy

Cancer immunotherapy is becoming more important in the clinical setting, especially for cancers resistant to conventional chemotherapy, including targeted therapy. Chimeric antigen receptor (CAR)-T cell therapy, which uses patient’s autologous T cells, combined with engineered T cell receptors, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hyunmin, Jung, Haiyoung, Noh, Ji-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621681/
https://www.ncbi.nlm.nih.gov/pubmed/34830003
http://dx.doi.org/10.3390/ijms222212126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621681/
https://www.ncbi.nlm.nih.gov/pubmed/34830003
http://dx.doi.org/10.3390/ijms222212126

Ejemplares similares